Biochemical activity of a hybrid liver support system based on porcine liver cells was investigated in patients suffering from acute liver failure, coma stage III-IV. Patient plasma was drawn systemically and after circulation through the bioreactor at four hour intervals. A method is used that takes into account the rate of plasma flow and the differences in plasma concentration systemically and after circulation through the liver support system to determine the net release or uptake of metabolites such as ammonia, urea and glucose. Urea release (mean 2.28 ± 0.37 μmol/h/g cells) and ammonia uptake (mean 0.17 ± 0.11 μmol/h/g cells) was seen during treatment, an active role of the system in glucose metabolism was observed. All patients were bridged successfully to liver transplantation.
ChariR.S., CollinsB.H., MageeJ.C.Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation.N Engl J Med1994; 331: 234–7.
4.
AbounaG.M., CookJ.S., FisherL.M., StillW.J., CostaG., HumeD.M.. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions.Surgery1972; 71: 537–46.
5.
SatohS., TerajimaH., YagiT.Humoral injury in porcine livers perfused with human whole blood.Transplantation1997; 64: 1117–23.
6.
FoxI.J., LangnasA.N., FristoeL.W.Successful application of extracorporeal liver perfusion: a technology whose time has come.Am J Gastroenterol1993; 88: 1876–81.
7.
SilvaY.J., ParameswaranP.G., JamesP.. Exchange transfusion and major surgery in acute hepatic failure.Surgery1976; 80: 343–9.
8.
HorisawaM., ReynoldsT.B.. Exchange transfusion in hepatorenal syndrome with liver disease.Arch Intern Med1976; 136: 1135–7.
9.
KondrupJ., AlmdalT., VilstrupH., TygstrupN.. High volume plasma exchange in fulminant hepatic failure.Int J Artif Organs1992; 15: 669–76.
McCauleyJ., GaynordM., HrinyaM., StarzlT.E.. Dialysis in liver failure and liver transplantation.Transplant Proc1993; 25: 1740.
12.
AshS.R.. Hemodiabsorption in the treatment of acute hepatic failure.ASAIO J1994; 40: 80–2.
13.
O'GradyJ.G., GimsonA.E., O'BrienC.J., PucknellA., HughesR.D., WilliamsR.. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.Gastroenterology1988; 94: 1186–92.
14.
ArkadopoulosN., DetryO., RozgaJ., DemetriouA.A.. Liver assist systems: state of the art.Int J Artif Organs1998; 21: 781–7.
15.
GerlachJ.C.. Development of a hybrid liver support system: a review.Int J Artif Organs1996; 19: 645–54.
16.
MargulisM.S., ErukhimovE.A., AndreimanL.A., ViksnaL.M.. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency.Resuscitation1989; 18: 85–94.
17.
SussmanN.L., KellyJ.H.. Extracorporeal liver support: cell-based therapy for the failing liver.Am J Kidney Dis1997; 30(5 suppl 4): S66–71.
18.
HeringS., GriffinB.E., StraussM.. Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen.Exp Cell Res1991; 195: 1–7.
19.
KimB.H., SungS.R., ChoiE.H.Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage.Exp Mol Med2000; 32: 29–37.
20.
SandigV., HofmannC., SteinertS., JenningsG., SchlagP., StraussM.. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors.Hum Gene Ther1996; 7: 1937–45.
21.
EnosawaS., SuzukiS., FujinoM.An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell.Cell Transplant1997; 6: 537–40.
22.
AlisonM.R., GoldingM.H., SarrafC.E.. Pluripotential liver stem cells: facultative stem cells located in the biliary tree.Cell Prolif1996; 29: 373–402.
23.
BrillS., HolstP., SigalS.Hepatic progenitor populations in embryonic, neonatal, and adult liver.Proc Soc Exp Biol Med1993; 204: 261–9.
24.
RozgaJ., HolzmanM.D., RoM.S.Development of a hybrid bioartificial liver.Ann Surg1993; 217: 502–9.
25.
WatanabeF.D., DemetriouA.A.. Support of acute liver failure patients with a bioartificial liver.J Clin Apheresis1996; 11: 138–42.
26.
WatanabeF.D., MullonC.J., HewittW.R.Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.Ann Surg1997; 225: 484–91.
27.
MargulisM.S., ErukhimovE.A., AndreimanL.A.The use of hemoperfusion through a suspension of cryopreserved hepatocytes in acute liver failure.Vestn Khir Im I I Grek1992; 148: 83–7.
28.
SeglenP.O.. Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver.Exp Cell Res1972; 74: 450–4.
29.
SeglenP.O.. Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion.Exp Cell Res1973; 76: 25–30.
30.
SeglenP.O.. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion.Exp Cell Res1973; 82: 391–8.
31.
GerlachJ.C., BrombacherJ., KloppelK., SchnoyN., NeuhausP.. Comparison of four methods for mass hepatocyte isolation from pig and human livers.Transplantation1994; 57: 1318–22.
32.
GerlachJ., BrombacherJ., SmithM., NeuhausP.. High yield hepatocyte isolation from pig livers for investigation of hybrid liver support systems: influence of collagenase concentration and body weight.J Surg Res1996; 62: 85–9.
33.
PlevrisJ.N., SchinaM., HayesP.C.. Review article: the management of acute liver failure.Aliment Pharmacol Ther1998; 12: 405–18.
34.
HazellA.S., ButterworthR.F.. Hepatic encephalopathy: An update of pathophysiologic mechanisms.Proc Soc Exp Biol Med1999; 222: 99–112.
35.
ZieveL.. The mechanism of hepatic coma.Hepatology1981; 1: 360–5.
36.
HaussingerD.. Nitrogen metabolism in liver: structural and functional organization and physiological relevance.Biochem J1990; 267: 281–90.
